The international Prognostic Index for patients with CLL (CLL-IPI): An international meta-analysis

被引：0
|
作者：
Kutsch, Nadine
Bahlo, Jasmin
Byrd, John C.
Dohner, Hartmut
Eichhorst, Barbara
Else, Monica
Geisler, Christian
Grever, Michael R.
Lepretre, Stephane
Bergman, Manuela
Neuberg, Donna S.
Oscier, David
Rosenquist, Richard
Robak, Tadeusz
Shanafelt, Tait D.
Stilgenbauer, Stephan
Hallek, Michael J.
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany
[3] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[4] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
[5] Inst Canc Res London, Div Mol Pathol, London, England
[6] Rigshosp, DK-2100 Copenhagen, Denmark
[7] Ohio State Univ, Columbus, OH 43210 USA
[8] Henri Becquerel Hosp, Rouen, France
[9] Klinikum Schwabing, Dept Hematol Oncol Immunol Palliat Care Infect Di, Munich, Germany
[10] Dana Farber Canc Inst, Boston, MA 02115 USA
[11] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England
[12] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden
[13] Med Univ Lodz, Lodz, Poland
[14] Mayo Clin, Rochester, MN USA
[15] Univ Hosp Ulm, Ulm, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7002
引用
收藏
页数：1
相关论文
共 50 条
  • [21] USEFULNESS OF THE PROGNOSTIC ESTIMATION OF THE CLL-IPI INDEX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA UNDER TREATMENT WITH IBRUTINIB
    Perez, Lamas Lucia
    Marquet, Palomanes Juan
    Nunez-Torron, Claudia
    Jimenez, Chillon Carlos
    Astibia, Mahillo Beatriz
    Piris, Villaespesa Miguel
    Martin, Moro Fernando
    Lario, Arribas Ana
    Herrera, Puente Pilar
    Lopez, Jimenez Javier
    [J]. HAEMATOLOGICA, 2020, 105 : 64 - 65
  • [22] APLICATION OF THE CLL-IPI AND THE MDACC PRGNOSTIC INDEXES IN A LOCAL COHORT OF CLL PATIENTS
    Gonzalez-Gascon Y Marin, I.
    Poza, M.
    Hernandez-Sanchez, M.
    Rodriguez-Vicente, A. E.
    Infante, M. S.
    Munoz Novas, C. C.
    Heras, C.
    Foncillas, M. A.
    Hernandez-Rivas, J. M.
    Hernandez, J. A.
    [J]. HAEMATOLOGICA, 2017, 102 : 427 - 427
  • [23] CLL-IPI applied in Binet A CLL: a nationwide cohort study
    Rotbain, Emelie C.
    da Cunha-Bang, Caspar
    Brieghel, Christian
    Niemann, Carsten U.
    [J]. BLOOD ADVANCES, 2022, 6 (21) : 5698 - 5701
  • [24] Validity and reproducibility of the CLL-IPI and the MDACC prognostic indexes in a cohort of Spanish patients
    Teresa Gonzalez-Gascon, Isabel
    Poza, Maria
    Hernandez Sanchez, Maria
    Eugenia Rodriguez-Vicente, Ana
    Stefania Infante, Maria
    Munoz, Carolina
    Heras, Cecilia
    Angeles Foncillas, Maria
    Marin, Karen
    Maria Hernandez, Jesus
    Angel Hernandez-Rivas, Jose
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 : 113 - 114
  • [25] CLL-IPI for Macedonian Patients with Chronic Lymphocytic Leukemia
    Trajkova, Sanja
    Cevreska, Lidija
    Ivanovski, Martin
    Popova-Labacevska, Marija
    Pivkova-Veljanovska, Aleksandra
    Panovska-Stavridis, Irina
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S212 - S212
  • [26] ASSESSING TIME TO FIRST TREATMENT IN EARLY CLL: A COMPARATIVE PERFORMANCE ANALYSIS OF FIVE PROGNOSTIC MODELS WITH INCLUSION OF CLL-IPI
    Molica, S.
    Giannarelli, D.
    Gentile, M.
    Mirabelli, R.
    Levato, L.
    Morabito, F.
    [J]. HAEMATOLOGICA, 2016, 101 : 434 - 434
  • [27] AN EVALUATION OF THE CLL-IPI SCORE AND COMPREHENSIVE PROGNOSTIC FACTOR ANALYSIS IN PATIENTS WITH R/R CLL IN IDELALISIB PHASE 3 RANDOMIZED STUDIES
    Soumerai, J. D.
    Barrientos, J. C.
    Hallek, M.
    Kipps, T. J.
    Jones, J. A.
    Xing, G.
    Yao, N. S.
    Ysebaert, L.
    Stilgenbauer, S.
    Zelenetz, A. D.
    [J]. HAEMATOLOGICA, 2016, 101 : 53 - 54
  • [28] VALIDATION OF THE NEW INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL-IPI) AND MODIFIED SCORE USED IN THE MD ANDERSON CANCER CENTER (MDACC)
    Isabel, Gonzalez-Gascon y Marin
    Maria, Poza
    Sanchez Maria, Hernandez
    Ana Eugenia, Rodriguez Vicente
    Maria, Infante
    Maria Angeles, Foncillas
    Karen, Marin
    Novas Carolina, Munoz
    Cecilia, Heras
    Jesus Maria, Hernandez Rivas
    Jose Angel, Hernandez
    [J]. HAEMATOLOGICA, 2016, 101 : 338 - 338
  • [29] CLL-IPI: valid in the era of oral inhibitors?
    Kutsch, Nadine
    [J]. BLOOD, 2021, 138 (02) : 106 - 107
  • [30] In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI
    Rigolin, Gian Matteo
    Cavallari, Maurizio
    Quaglia, Francesca Maria
    Formigaro, Luca
    Lista, Enrico
    Urso, Antonio
    Guardalben, Emanuele
    Liberatore, Carmine
    Faraci, Danilo
    Saccenti, Elena
    Bassi, Cristian
    Lupini, Laura
    Bardi, Maria Antonella
    Volta, Eleonora
    Tammiso, Elisa
    Melandri, Aurora
    Negrini, Massimo
    Cavazzini, Francesco
    Cuneo, Antonio
    [J]. BLOOD, 2017, 129 (26) : 3495 - 3498
12345